Lysin Cf-301 (streptococcus Suis Phage) Uses, Dosage, Side Effects and more
Lysin Cf-301 (streptococcus Suis Phage) is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia).
| Attribute | Details |
|---|---|
| Trade Name | Lysin Cf-301 (streptococcus Suis Phage) |
| Generic | Exebacase |
| Exebacase Other Names | Des-met1-putative phage lysin (streptococcus phage phi891591), produced in escherichia coli, Exebacase, Lysin cf-301 (streptococcus suis phage), Lysin plyss2 (streptococcus suis phage) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
